These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23088155)

  • 1. Studies toward the unique pederin family member psymberin: structure-activity relationships, biochemical studies, and genetics identify the mode-of-action of psymberin.
    Wu CY; Feng Y; Cardenas ER; Williams N; Floreancig PE; De Brabander JK; Roth MG
    J Am Chem Soc; 2012 Nov; 134(46):18998-9003. PubMed ID: 23088155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of psymberin analogues: probing a functional correlation with the pederin/mycalamide family of natural products.
    Jiang X; Williams N; De Brabander JK
    Org Lett; 2007 Jan; 9(2):227-30. PubMed ID: 17217271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies toward the unique pederin family member psymberin: full structure elucidation, two alternative total syntheses, and analogs.
    Feng Y; Jiang X; De Brabander JK
    J Am Chem Soc; 2012 Oct; 134(41):17083-93. PubMed ID: 23004238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogs.
    Huang X; Shao N; Huryk R; Palani A; Aslanian R; Seidel-Dugan C
    Org Lett; 2009 Feb; 11(4):867-70. PubMed ID: 19199777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family.
    Cichewicz RH; Valeriote FA; Crews P
    Org Lett; 2004 Jun; 6(12):1951-4. PubMed ID: 15176791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis and biological evaluation of pederin, psymberin, and highly potent analogs.
    Wan S; Wu F; Rech JC; Green ME; Balachandran R; Horne WS; Day BW; Floreancig PE
    J Am Chem Soc; 2011 Oct; 133(41):16668-79. PubMed ID: 21902245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, biological activity, synthesis, and medicinal chemistry of the pederin/mycalamide family of natural products.
    Mosey RA; Floreancig PE
    Nat Prod Rep; 2012 Sep; 29(9):980-95. PubMed ID: 22772477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward the total synthesis of psymberin/irciniastatin A.
    Brown LE; Landaverry YR; Davies JR; Milinkevich KA; Ast S; Carlson JS; Oliver AG; Konopelski JP
    J Org Chem; 2009 Aug; 74(15):5405-10. PubMed ID: 19572569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The total synthesis of psymberin.
    Huang X; Shao N; Palani A; Aslanian R; Buevich A
    Org Lett; 2007 Jun; 9(13):2597-600. PubMed ID: 17523653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycalamides, pederin and psymberin as natural carbohydrates and potential antitumor agents: past and future perspectives.
    Witczak ZJ; Rampulla RM; Bommareddy A
    Mini Rev Med Chem; 2012 Dec; 12(14):1520-32. PubMed ID: 22827176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and complete stereochemical assignment of psymberin/irciniastatin A.
    Jiang X; García-Fortanet J; De Brabander JK
    J Am Chem Soc; 2005 Aug; 127(32):11254-5. PubMed ID: 16089449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro biological activities of synthetic 18-O-methyl mycalamide B, 10-epi-18-O-methyl mycalamide B and pederin.
    Richter A; Kocienski P; Raubo P; Davies DE
    Anticancer Drug Des; 1997 Apr; 12(3):217-27. PubMed ID: 9154112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis of irciniastatin A (Psymberin).
    Crimmins MT; Stevens JM; Schaaf GM
    Org Lett; 2009 Sep; 11(17):3990-3. PubMed ID: 19670853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configuration of the psymberin amide side chain.
    Kiren S; Williams LJ
    Org Lett; 2005 Jul; 7(14):2905-8. PubMed ID: 15987166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Synthesis and Biological Evaluation of Irciniastatin A (a.k.a. Psymberin) and Irciniastatin B.
    Uesugi S; Watanabe T; Imaizumi T; Ota Y; Yoshida K; Ebisu H; Chinen T; Nagumo Y; Shibuya M; Kanoh N; Usui T; Iwabuchi Y
    J Org Chem; 2015 Dec; 80(24):12333-50. PubMed ID: 26544018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and biological evaluation of irciniastatin A and the C1-C2 alkyne analogue.
    Watanabe T; Imaizumi T; Chinen T; Nagumo Y; Shibuya M; Usui T; Kanoh N; Iwabuchi Y
    Org Lett; 2010 Mar; 12(5):1040-3. PubMed ID: 20141170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psymberin story--biological properties and approaches towards total and analogue syntheses.
    Bielitza M; Pietruszka J
    Angew Chem Int Ed Engl; 2013 Oct; 52(42):10960-85. PubMed ID: 24105772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irciniastatin A induces JNK activation that is involved in caspase-8-dependent apoptosis via the mitochondrial pathway.
    Chinen T; Nagumo Y; Watanabe T; Imaizumi T; Shibuya M; Kataoka T; Kanoh N; Iwabuchi Y; Usui T
    Toxicol Lett; 2010 Dec; 199(3):341-6. PubMed ID: 20920557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical assignment of the C1-C6 fragment of psymberin by synthesis and natural product degradation.
    Green ME; Rech JC; Floreancig PE
    Org Lett; 2005 Sep; 7(19):4117-20. PubMed ID: 16146366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition.
    Dayanidhi DL; Somarelli JA; Mantyh JB; Rupprecht G; Roghani RS; Vincoff S; Shin I; Zhao Y; Kim SY; McCall S; Hong J; Hsu DS
    Front Med (Lausanne); 2022; 9():999004. PubMed ID: 36743670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.